Arsenal Capital Partners Acquires Caprion Biosciences from GHO Capital

Caprion Biosciences Acquires Serametrix Corporation

May 8, 2019

Healthcare Services

Caprion Biosciences, a GHO Capital portfolio company, has acquired Serametrix Corporation, a CLIA-certified immune monitoring services provider headquartered in Carlsbad, California. The deal expands Caprion's immunology biomarker capabilities—notably Serametrix's MDSC analysis expertise—and extends Caprion's global footprint with Serametrix's operations in the US, UK, Australia and China.

Caprion-HistoGeneX Acquires Clinical Logistics Inc.

January 7, 2021

Healthcare Services

Caprion-HistoGeneX, a portfolio company backed by Arsenal Capital Partners, has acquired Clinical Logistics Inc. (CLI), a Halifax-based virtual central specimen management CRO. The acquisition expands Caprion-HistoGeneX’s specimen logistics and kitting capabilities to better support global clinical trial operations and specialty specimen handling for pharmaceutical and biotech customers.

Arsenal Capital Partners Acquires Accumen

January 17, 2019

Healthcare Services

Arsenal Capital Partners, a New York-based private equity firm, has acquired Accumen Inc., a technology-enabled provider of health system performance optimization solutions, from Accretive, LLC. Terms were not disclosed; Arsenal said it will support Accumen's growth and expand its technology-enabled services for clinical laboratories, outreach services, patient blood management, and imaging services.

Arsenal Capital Partners Recapitalizes Headwall Photonics

January 20, 2022

Manufacturing

Arsenal Capital Partners led a recapitalization of Headwall Photonics, becoming the majority owner in partnership with the company’s existing management and ownership. The deal will provide Headwall — a designer and manufacturer of hyperspectral imaging systems, spectral instrumentation, and optical components — with capital to accelerate product development and pursue organic and inorganic growth opportunities.

Arsenal Capital Partners Acquires Majority Stake in OncoHealth; McKesson Makes Strategic Investment

May 9, 2022

Healthcare Services

Arsenal Capital Partners has acquired a majority ownership stake in OncoHealth, a digital health company focused on oncology, with McKesson Corporation making a strategic minority investment. Baird Capital, the prior investor, will retain a minority equity stake; financial terms were not disclosed. The investments are intended to accelerate OncoHealth’s product innovation, expansion of oncology digital solutions, and market growth.

GHO Capital Partners Acquires Majority Stake in Sapio Sciences

December 1, 2022

Cloud & SaaS

London-based healthcare investor GHO Capital Partners has acquired a majority stake in Sapio Sciences, a US-based lab informatics platform providing LIMS, ELN and scientific data management solutions. GHO will support Sapio's international expansion (especially into Europe), operational improvements and growth through M&A to scale the company's SaaS offering for biopharma, CROs and diagnostic labs.